FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-01 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-03 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-02 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-27 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-05 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-07 | Fentanyl Citrate | 50 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-01 | Fentanyl Citrate | 50 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-04 | Fentanyl Citrate | 50 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-16 | Fentanyl Citrate | 50 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-157 | 73177-157-01 | Furosemide | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-157 | 73177-157-03 | Furosemide | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-101 | 73177-101-02 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-101 | 73177-101-06 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-06 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-03 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-113 | 73177-113-12 | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 9 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-149 | 73177-149-35 | Methadone Hydrochloride | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-149 | 73177-149-03 | Methadone Hydrochloride | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-04 | Midazolam | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-05 | Midazolam | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-01 | Midazolam | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-01 | Morphine Sulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-05 | Morphine Sulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-02 | Morphine Sulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-04 | Morphine Sulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-16 | Morphine Sulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-30 | Morphine Sulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0042 | 81483-0042-0 | Sodium Chloride | 9 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Tailstorm Health INC | 118651212 | 81483-0041 | 81483-0041-5 | Bevacizumab | 1.25 mg/.05 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0003 | 81483-0003-0 | Bupivacaine Hydrochloride | 2.5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0035 | 81483-0035-0 | Bupivacaine Hydrochloride; Epinephrine Bitartrate | 2.5 mg/1 mL; 5 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0036 | 81483-0036-0 | Epinephrine Bitartrate; Bupivacaine Hydrochloride | 5 ug/1 mL; 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0007 | 81483-0007-0 | Ketamine Hydrochloride | 100 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0006 | 81483-0006-0 | Ketamine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0038 | 81483-0038-0 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 20 mg/1 mL; 5 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0037 | 81483-0037-0 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 10 mg/1 mL; 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-501 | 65302-501-03 | Neostigmine Methylsulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-506 | 65302-506-10 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| The Ritedose Corporation | 837769546 | 65302-505 | 65302-505-10 | Phenylephrine Hydrochloride | 80 ug/1 mL | 2023-2 | valid | 2026-11-08 |